These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15277015)

  • 1. Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 substrate interactions.
    Lewis DF; Lake BG; Dickins M; Goldfarb PS
    Xenobiotica; 2004 Jun; 34(6):549-69. PubMed ID: 15277015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template.
    Lewis DF
    J Inorg Biochem; 2002 Sep; 91(4):502-14. PubMed ID: 12237218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the CYP3A4 active site by homology modeling.
    Tanaka T; Okuda T; Yamamoto Y
    Chem Pharm Bull (Tokyo); 2004 Jul; 52(7):830-5. PubMed ID: 15256703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology modelling of human CYP1A2 based on the CYP2C5 crystallographic template structure.
    Lewis DF; Lake BG; Dickins M; Ueng YF; Goldfarb PS
    Xenobiotica; 2003 Mar; 33(3):239-54. PubMed ID: 12637242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology modelling of CYP2A6 based on the CYP2C5 crystallographic template: enzyme-substrate interactions and QSARs for binding affinity and inhibition.
    Lewis DF; Lake BG; Dickins M; Goldfarb PS
    Toxicol In Vitro; 2003 Apr; 17(2):179-90. PubMed ID: 12650672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme-substrate interactions.
    Lewis DF; Lake BG; Dickins M; Goldfarb PS
    Drug Metabol Drug Interact; 2002; 19(2):115-35. PubMed ID: 12751910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular model of CYP2D6 constructed by homology with the CYP2C5 crystallographic template: investigation of enzyme-substrate interactions.
    Lewis DF; Dickins M; Lake BG; Goldfarb PS
    Drug Metabol Drug Interact; 2003; 19(3):189-210. PubMed ID: 14682610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure.
    Lewis DF
    Xenobiotica; 2002 Apr; 32(4):305-23. PubMed ID: 12028664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals.
    Lewis DF; Eddershaw PJ; Goldfarb PS; Tarbit MH
    Xenobiotica; 1996 Oct; 26(10):1067-86. PubMed ID: 8905920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of enzyme selectivity in the human CYP2C subfamily: homology modelling of CYP2C8, CYP2C9 and CYP2C19 from the CYP2C5 crystallographic template.
    Lewis DF; Dickins M; Lake BG; Goldfarb PS
    Drug Metabol Drug Interact; 2003; 19(4):257-85. PubMed ID: 14768974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating human P450s involved in drug metabolism via homology with high-resolution P450 crystal structures of the CYP2C subfamily.
    Lewis DF; Ito Y; Goldfarb PS
    Curr Drug Metab; 2006 Aug; 7(6):589-98. PubMed ID: 16918314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology modeling of human 25-hydroxyvitamin D3 1alpha-hydroxylase (CYP27B1) based on the crystal structure of rabbit CYP2C5.
    Yamamoto K; Masuno H; Sawada N; Sakaki T; Inouye K; Ishiguro M; Yamada S
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):167-71. PubMed ID: 15225767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of coumarin by human P450s: a molecular modelling study.
    Lewis DF; Ito Y; Lake BG
    Toxicol In Vitro; 2006 Mar; 20(2):256-64. PubMed ID: 16157466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structure.
    Lewis DF; Lee-Robichaud P
    J Steroid Biochem Mol Biol; 1998 Aug; 66(4):217-33. PubMed ID: 9744519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined three-dimensional quantitative structure-activity relationship analysis of cytochrome P450 2B6 substrates and protein homology modeling.
    Wang Q; Halpert JR
    Drug Metab Dispos; 2002 Jan; 30(1):86-95. PubMed ID: 11744616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a combined protein and pharmacophore model for cytochrome P450 2C9.
    de Groot MJ; Alex AA; Jones BC
    J Med Chem; 2002 May; 45(10):1983-93. PubMed ID: 11985466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzyme-substrate and enzyme-inhibitor interactions.
    Lewis DF; Lake BG; Bird MG; Loizou GD; Dickins M; Goldfarb PS
    Toxicol In Vitro; 2003 Feb; 17(1):93-105. PubMed ID: 12537967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for communality in the primary determinants of CYP74 catalysis and of structural similarities between CYP74 and classical mammalian P450 enzymes.
    Hughes RK; Yousafzai FK; Ashton R; Chechetkin IR; Fairhurst SA; Hamberg M; Casey R
    Proteins; 2008 Sep; 72(4):1199-211. PubMed ID: 18338380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity.
    Lewis DF
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):369-74. PubMed ID: 10445400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.